Exhibit 3.2
Registrar of Companies
Government Administration
Building 133 Elgin Avenue
George Town
Grand Cayman
Ambrx Biopharma Inc. (ROC#299705) (the "Company")
TAKE NOTICE that at an Annual General Meeting of the Company held on 7 June 2023, the following resolution was passed:
Approval of an increase in the authorized share capital from US$60,000 divided into 600,000,000 shares of US$0.0001 each to US$105,000 divided into (a) 950,000,000 ordinary shares of US$0.0001 each, and (b) 100,000,000 shares of US$0.0001 each of such class or classes (however designated) as the Board may determine in accordance with the Company’s memorandum and articles of association, by the creation of (i) 350,000,000 ordinary shares of US$0.0001 each and (ii) 100,000,000 shares of US$0.0001 each of such class or classes (however designated) as the Board may determine in accordance with the Company’s memorandum and articles of association.
/s/ Sophia Marsh
Sophia Marsh
Senior Corporate Administrator
for and on behalf of
Maples Corporate Services Limited
Dated this 14th day of June 2023.
Filed: 14-Jun-2023 13:26 EST
Auth Code: K85427780376
www.verify.gov.ky File#: 299705
